This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
SIU 2017
SIU 2017 Kidney Cancer
Conferences
AUA 2014
SIU 2017
Prostate Cancer
Kidney Cancer
Bladder Cancer
AUA 2014 - Renal Cancer
Viewing 21-37 of 37 articles
#AUA14 - The role of obesity in the incidence of lymphatic spread, disease-free and overall survival: Data from the ARISER clinical trial - Session Highlights
#AUA14 - Poster: Patients with anatomically “simple” renal masses are more likely to be placed on active surveillance than those with anatomically “complex” lesions
#AUA14 - Survival and prognostic variables predicting survival in T4 renal cell carcinoma - Session Highlights
#AUA14 - Statin use for dyslipidemia is associated with improved oncologic outcomes of surgically treated renal cell carcinoma - Session Highlights
#AUA14 - Validation of the Renal Pelvic Score: A novel marker of renal pelvic anatomy that predicts urine leak following partial nephrectomy - Session Highlights
#AUA14 - Mental health is not affected by active surveillance for patients with small renal masses: Quality of life results from the DISSRM registry - Session Highlights
#AUA14 - National trends in the management of benign renal masses: A 14-year survey of the Nationwide Inpatient Sample - Session Highlights
#AUA14 - Histologic analysis of tumor-parenchyma interface in patients with renal neoplasms - Session Highlights
#AUA14 - Improving renal needle-biopsy accuracy with RCC-specific DNA methylation markers - Session Highlights
#AUA14 - Quantification of renal cell optical biomarkers using second harmonic generation imaging - Session Highlights
#AUA14 - Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection - Session Highlights
#AUA14 - Can multiphase CT scan distinguish between type 1 and type 2 papillary renal cell carcinoma? A retrospective analysis - Session Highlights
#AUA14 - Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma - Session Highlights
#AUA14 - Gain of chromosome 8q is associated with inferior survival in patients with renal cell carcinoma - Session Highlights
#AUA14 - Poster: Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma
#AUA14 - Predictive models for cytoreduction - Session Highlights
#AUA14 - Anti-PD1 agents in kidney cancer - Session Highlights
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free